Here's when coronavirus vaccines will be rolled out in advanced economies, according to Goldman Sachs
Goldman Sachshas predicted when coronavirusvaccines will be rolled out as several candidates approach regulatory approval in advanced economies.
- More than 70% of people in developed economies can expect to be immunized by fall 2021, economists Daan Struyven and Sid Bhushan said.
- The UK will vaccinate half of its population by March, with the US and Canada doing the same by April.
- The EU, Japan, and Australia can expect to reach the same level of immunization by May.
Goldman Sachs has laid out a timeline for when coronavirus vaccines will be rolled out in advanced economies.
The bank's predicted timing is based on a combination of supply estimates — from vaccine developers Pfizer-BioNTech, Moderna, AstraZeneca-Oxford, Novavax, and Johnson & Johnson — and demand (using consumer surveys).
More than 70% of people in developed
On Monday, the UK became the first country to approve Pfizer and BioNTech's vaccine shot, marking a major relief for economies and travel-dependent sectors around the world.
Economists Daan Struyven and Sid Bhushan said they expect the first available doses in the US to go to high-risk groups from mid-December. That would point to significant health benefits by the first quarter of 2021, they said, followed by widespread vaccination from April.
In all major developed markets, large parts of the population are expected to be vaccinated by fall 2021.
The UK is expected to have vaccinated half of its population by March, with the US and Canada likely having done so shortly after by April, they said. The European Union, Japan, and Australia can expect to reach this level of immunization by May.
Children under the age of 12 could start being inoculated globally from October 2021.
Goldman Sachs predicted that the US FDA will approve Pfizer-BioNTech and
Based on comments from the European Commission President Ursula von der Leyen, the economists said leading vaccines will be approved for the European Union before the end of this year.
Daan Struyven and Sid Bhushan also laid out a downside scenario to project what happens if AstraZeneca and Johnson & Johnson's vaccines do not succeed, and demand weakens. That would imply a slower rate of vaccination in Europe, which is more reliant on these candidates.
But their baseline forecast is that widespread immunization will "drive a sharp pickup" in global growth starting in the second quarter of 2021.
Read More: Dennis Lynch has tripled his clients' money since 2010. The star fund manager shares 5 bets he's seizing on for 2021 and beyond — and explains how he avoids making costly investing decisions.
- Here is a list of bank holidays in October 2022
- An Apple executive is leaving the company after being filmed joking about fondling 'big-breasted women' in a viral TikTok video
- Toyota's president said he 'did a little happy dance' after the company dethroned GM to become the bestselling carmaker in the US last year
- Best camera phone under ₹15000
- Best 5G mobile phones under ₹20000
- 22 lakh Indian IT professionals likely to leave jobs by 2025: Report
- OnePlus says successfully geared up for 5G launch with 5G-ready smartphone portfolio
- This website generates videos from a single image and text for free – here’s all you need to know
- Tata Tiago Electric Car
- HCL Tech
- World Heart Day 2022
- Apple Tablets in Amazon Sale
- RBI Repo Rate
- Akash Ambani
- Amazon festival Sale
- Upcoming new Mobile in October
- Amazon Festival Sale
- Best Companies for Work
- India's Richest People
- RBI Interest Rate hike
- Upcoming Smartphone in 2022
- Top 10 Colleges in India
- Top 10 Airlines in World